Related Experiment Video
Updated: May 31, 2026
05:48
Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
Published on: March 16, 2022
The missing C-17 O-methyltransferase in geldanamycin biosynthesis
Min Yin1, Tao Lu, Li-Xing Zhao
1Yunnan Institute of Microbiology, Yunnan University, Kunming, Yunnan 650091, China.
Organic Letters
|June 21, 2011
Summary
Researchers identified the missing C-17 O-methyltransferase gene (gdmMT) crucial for geldanamycin (GDM) biosynthesis. This discovery advances understanding of Hsp90 inhibitor production in Streptomyces strains.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Geldanamycin (GDM) is a potent Hsp90 inhibitor with therapeutic potential.
- Previous studies cloned GDM biosynthetic gene clusters but failed to identify the C-17 O-methyltransferase gene.
- The precise genetic basis for GDM biosynthesis remained incomplete.
Purpose of the Study:
- To identify the unknown gene encoding the C-17 O-methyltransferase involved in geldanamycin biosynthesis.
- To characterize the GDM biosynthetic gene cluster from Streptomyces autolyticus CGMCC 0516.
Main Methods:
- Cloning and sequencing of the GDM biosynthetic gene cluster from Streptomyces autolyticus.
- Bioinformatic analysis to identify putative genes within the cluster.
- Functional characterization of the identified methyltransferase gene (gdmMT).
Main Results:
- A novel GDM biosynthetic gene cluster was successfully cloned and sequenced from Streptomyces autolyticus CGMCC 0516.
- The gene gdmMT was identified and confirmed to encode the missing C-17 O-methyltransferase.
- This enzyme is essential for the final steps of geldanamycin biosynthesis.
Conclusions:
- The identification of gdmMT completes the genetic blueprint for geldanamycin biosynthesis.
- This finding provides a foundation for metabolic engineering and synthetic biology approaches to GDM production.
- Understanding the complete biosynthetic pathway enhances knowledge of secondary metabolite production in Streptomyces.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...